Tokyo: Japan's health ministry has released, for the first time, five-year survival rates for new cancer patients by cancer type, using data from the country's national cancer registry. The report covers nearly 990,000 individuals diagnosed with cancer in 2016.

According to Philippines News Agency, among patients aged 15 and older, prostate cancer showed the highest five-year net survival rate at 92.1 percent among 88,961 cases, while pancreatic cancer had the lowest at 11.8 percent for 39,247 patients. Breast cancer patients had a survival rate of 88 percent out of 97,250 cases. Bowel cancer had a 67.8 percent survival rate among 159,093 cases, stomach cancer had a 64 percent rate for 132,588 cases, and lung cancer had a 37.7 percent rate from 123,791 cases.

For patients under the age of 15, the highest survival rate was 95.7 percent for 114 individuals diagnosed with lymphocyte or lymphoreticular tumors. Leukemia, lymphoproliferative disorders, and myelodysplastic syndrome showed an 82.2 percent survival rate among 436 patients, while central nervous system, intracranial, or spinal cord tumors had a 60.8 percent survival rate among 293 patients.